Stryker Corp(SYK) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 28.53 | EPS (ttm) | 9.65 | Insider Own | 5.9% | Shs Outstand | 383.6M | Perf Week | -13.24% |
| Market Cap | 105.63B | Forward P/E | 16.44 | EPS next Y | 11.55% | Insider Trans | -2.89% | Shs Float | 360.9M | Perf Month | -20.36% |
| Enterprise Value | 117.60B | PEG | 1.49 | EPS next Q | 3.58 | Inst Own | 82.4% | Short Float | 1.92% | Perf Quarter | -12.3% |
| Income | 3.73B | P/S | 4.09 | EPS this Y | 10.17% | Inst Trans | 1.12% | Short Ratio | 2.75 | Perf Half Y | -23.21% |
| Sales | 25.84B | P/B | 4.4 | EPS next 5Y | 11% | ROA | 7.91% | Short Interest | 6.94M | Perf YTD | -21.65% |
| Book/sh | 62.54 | P/C | 30.39 | EPS past 3/5Y | 10.83% 14.84% | ROE | 16.51% | 52W High | -30.44% ($395.90) | Perf Year | -29.88% |
| Cash/sh | 9.06 | P/FCF | 22.47 | Sales past 3/5Y | 10.83% 11.84% | ROIC | 9.68% | 52W Low | 0.11% ($275.10) | Perf 3Y | -4.89% |
| Dividend Est. | $3.53 (1.28%) | EV/EBITDA | 15.7 | EPS Y/Y TTM | 27.36% | Gross Margin | 62.97% | Volatility(W/M) | 4.69% 3.1% | Perf 5Y | -0.55% |
| Dividend TTM | 3.48 | EV/Sales | 4.55 | Sales Y/Y TTM | 8.48% | Oper. Margin | 24.27% | ATR (14) | 10.92 | Perf 10Y | 149.13% |
| Dividend Ex-Date | 2026/9/30 | Quick Ratio | 1.33 | EPS Q/Q | 44.49% | Profit Margin | 14.43% | RSI (14) | 24.46 | Recom | 1.57 |
| Dividend Gr. 3/5Y | 6.31% 7.67% | Current Ratio | 2.16 | Sales Q/Q | 9.42% | SMA20 | -14.54% ($322.24) | Beta | 0.78 | Target Price | $383.26 |
| Payout | 40.48% | Debt/Eq | 0.64 | Earnings | 2026/7/30 | SMA50 | -15.7% ($326.68) | Rel Volume | 2.17 | Prev Close | $276.43 |
| Employees | 56000 | LT Debt/Eq | 0.61 | EPS/Sales Surpr. | 5.78% 0.15% | SMA200 | -18.43% ($337.61) | Avg Volume(3M) | 2.52M | Price | $275.39 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 69375 | Volume | 5,473,729 | Change | -0.38% |
Company
SYK is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🦴 A global medical device company with an extensive medical device portfolio spanning orthopedics, neurosurgery, surgery, and emergency medicine. Founded in the United States in 1941 and headquartered in Kalamazoo, Michigan, it holds a leading position in the orthopedic surgical robotics (MAKO) and implant market, as well as in the surgical and emergency medical device markets.
Over the past 1 year, on the lower side
30% below its 1-year high.
Upcoming eventsNext ex-dividend (upcoming)
Ex-dividend September 30
SYK makes money exceptionally well
24.27% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +10.2% this year.
Tap to view numbers
The price looks about right
Trading at 28.5 times earnings.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -4.9% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 1.28% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 82.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IHI 0.12%
SEMG 0.04%
JGRW 0.04%
CWS 0.04%
AGNG 0.03%It ranks #3 in the industry
Based on market cap of $106B.
SYK $106B PER 28.5
ABT $182B PER 34.0
MDT $118B PER 22.6
BSX $65B PER 18.2
실적분석 · 7/30 Stryker ($SYK) Q2 2026 Earnings Analysis — Revenue and Adjusted EPS Beat Expectations, Shares Plunge After-Hours Despite Narrowed Outlook 투자 가이드 · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is SYK?
SYK belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SYK?
The market cap of SYK is approximately $105.6B, ranking 154 within its sector.
Does SYK pay dividends?
SYK has a dividend yield of approximately 1.28%, with an annual dividend of $3.53.
What is the P/E ratio of SYK?
SYK has a P/E ratio of approximately 28.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SYK?
SYK has recorded a 52-week high of $395.90 and a low of $275.10.
